ArticleActa ophthalmologica2026
Diabetic retinopathy in Greenland and Denmark-Can differences in risk factors explain the lower prevalence in Greenland?
Article in Acta ophthalmologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThe prevalence of diabetic retinopathy (DR) is low in Greenland. Factors underlying the low prevalence may potentially protect against the development of DR. Comparing Greenlandic and Danish populations, this register-based study explored differences in risk factors that may explain differences in DR prevalence.
methodsData on DR and risk factors from Greenlandic (n = 1941) and Danish (n = 110343) patients with diabetes were collected from 2019 to 2023 through the Greenlandic electronic medical health records system Cosmic, the Danish Adult Diabetes Registry and the Danish Registry of Diabetic Retinopathy, respectively. Logistic regression models were used to estimate odds and odds ratio (OR) of selected risk factors by cohort (Greenlandic or Danish). Furthermore, the ethnic difference in age and diabetes duration at DR screening was modelled using natural splines.
resultsThe prevalence of DR was 10.2% in the Greenlandic cohort and 20.9% in the Danish cohort. In multivariate analysis, longer DM duration and higher HbA1c were the most important risk factors of prevalent DR in both cohorts. DM duration longer than 15 years was associated with higher OR in the Danish cohort than in the Greenlandic. In the Danish cohort, overweight and obesity were associated with higher OR of DR (OR = 1.20, 95% CI = 1.02; 1.41 and OR = 1.24, 95% CI = 1.04; 1.48, respectively) while lower ORs were observed for overweight (OR 0.57 95% CI = 0.28; 1.15) or obesity (OR 0.56, 95% CI = 0.30; 1.07) in the Greenlandic cohort. High systolic blood pressure was also associated with prevalent DR in the Danish cohort.
conclusionLong DM duration was a more prominent risk factor for prevalent DR in the Danish population than in the Greenlandic population. Future studies may address the potentially lower sensitivity to DM duration in the Greenlandic population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.